Results of laser-assisted balloon angioplasty for peripheral arterial obstruction using a lensed fiber-tip delivery catheter

Christopher J. White, Stephen R. Ramee, Michael Aita, Gene Samson, Maureen Godfrey, Larry Hollier, Joseph P Murgo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Percutaneous transluminal balloon angioplasty of obstructed iliac and femoral arteries is the therapy of choice in the management of selected patients with peripheral vascular disease. The advantages of percutaneous balloon angioplasty include a reduction in the morbidity of the revascularization procedure, a shorter hospital stay, and comparable 5-year patency rates when compared with surgical revascularization in selected patients.1,2 One of the limitations of balloon angioplasty is that a lesion must first be crossed with a guidewire. The inability to cross occlusions with a guidewire is the most common cause of failure of the procedure. Laser angioplasty may have a role as an adjunct to balloon angioplasty by recanalizing lesions that cannot be traversed with a guidewire. The laser can create a channel through the arterial occlusion allowing the balloon catheter to be advanced across the lesion to further reduce the arterial stenosis. Early clinical trials of laser angioplasty in the peripheral arteries have demonstrated the unsatisfactory results obtained with single bare optical fibers used to deliver the laser energy due to the small channels created,3 and the high incidence of arterial perforatior not only increase the size of the lumen created with the laser fiber but also reduce the risk of mechanical perforation, we have modified the distal end with a spherical lens that increases the spot size of the laser fiber and provides an atraumatic tip for the optical fiber. This report describes the first human clinical trials including 6-month follow-up of patients treated with a lensed fiber-tip laser delivery system designed for percutaneous revascularization of peripheral vascular obstructive lesions not amenable to conventional balloon angioplasty.

Original languageEnglish (US)
Pages (from-to)1526-1528
Number of pages3
JournalThe American Journal of Cardiology
Volume66
Issue number20
DOIs
StatePublished - Dec 15 1990
Externally publishedYes

Fingerprint

Laser-Assisted Balloon Angioplasty
Balloon Angioplasty
Lasers
Catheters
Laser Angioplasty
Optical Fibers
Clinical Trials
Balloon Occlusion
Peripheral Vascular Diseases
Iliac Artery
Femoral Artery
Angioplasty
Lenses
Blood Vessels
Length of Stay
Pathologic Constriction
Arteries
Morbidity
Incidence

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Results of laser-assisted balloon angioplasty for peripheral arterial obstruction using a lensed fiber-tip delivery catheter. / White, Christopher J.; Ramee, Stephen R.; Aita, Michael; Samson, Gene; Godfrey, Maureen; Hollier, Larry; Murgo, Joseph P.

In: The American Journal of Cardiology, Vol. 66, No. 20, 15.12.1990, p. 1526-1528.

Research output: Contribution to journalArticle

White, Christopher J. ; Ramee, Stephen R. ; Aita, Michael ; Samson, Gene ; Godfrey, Maureen ; Hollier, Larry ; Murgo, Joseph P. / Results of laser-assisted balloon angioplasty for peripheral arterial obstruction using a lensed fiber-tip delivery catheter. In: The American Journal of Cardiology. 1990 ; Vol. 66, No. 20. pp. 1526-1528.
@article{f0ac3cb3bb7646d3b981df3f734e2929,
title = "Results of laser-assisted balloon angioplasty for peripheral arterial obstruction using a lensed fiber-tip delivery catheter",
abstract = "Percutaneous transluminal balloon angioplasty of obstructed iliac and femoral arteries is the therapy of choice in the management of selected patients with peripheral vascular disease. The advantages of percutaneous balloon angioplasty include a reduction in the morbidity of the revascularization procedure, a shorter hospital stay, and comparable 5-year patency rates when compared with surgical revascularization in selected patients.1,2 One of the limitations of balloon angioplasty is that a lesion must first be crossed with a guidewire. The inability to cross occlusions with a guidewire is the most common cause of failure of the procedure. Laser angioplasty may have a role as an adjunct to balloon angioplasty by recanalizing lesions that cannot be traversed with a guidewire. The laser can create a channel through the arterial occlusion allowing the balloon catheter to be advanced across the lesion to further reduce the arterial stenosis. Early clinical trials of laser angioplasty in the peripheral arteries have demonstrated the unsatisfactory results obtained with single bare optical fibers used to deliver the laser energy due to the small channels created,3 and the high incidence of arterial perforatior not only increase the size of the lumen created with the laser fiber but also reduce the risk of mechanical perforation, we have modified the distal end with a spherical lens that increases the spot size of the laser fiber and provides an atraumatic tip for the optical fiber. This report describes the first human clinical trials including 6-month follow-up of patients treated with a lensed fiber-tip laser delivery system designed for percutaneous revascularization of peripheral vascular obstructive lesions not amenable to conventional balloon angioplasty.",
author = "White, {Christopher J.} and Ramee, {Stephen R.} and Michael Aita and Gene Samson and Maureen Godfrey and Larry Hollier and Murgo, {Joseph P}",
year = "1990",
month = "12",
day = "15",
doi = "10.1016/0002-9149(90)90553-D",
language = "English (US)",
volume = "66",
pages = "1526--1528",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "20",

}

TY - JOUR

T1 - Results of laser-assisted balloon angioplasty for peripheral arterial obstruction using a lensed fiber-tip delivery catheter

AU - White, Christopher J.

AU - Ramee, Stephen R.

AU - Aita, Michael

AU - Samson, Gene

AU - Godfrey, Maureen

AU - Hollier, Larry

AU - Murgo, Joseph P

PY - 1990/12/15

Y1 - 1990/12/15

N2 - Percutaneous transluminal balloon angioplasty of obstructed iliac and femoral arteries is the therapy of choice in the management of selected patients with peripheral vascular disease. The advantages of percutaneous balloon angioplasty include a reduction in the morbidity of the revascularization procedure, a shorter hospital stay, and comparable 5-year patency rates when compared with surgical revascularization in selected patients.1,2 One of the limitations of balloon angioplasty is that a lesion must first be crossed with a guidewire. The inability to cross occlusions with a guidewire is the most common cause of failure of the procedure. Laser angioplasty may have a role as an adjunct to balloon angioplasty by recanalizing lesions that cannot be traversed with a guidewire. The laser can create a channel through the arterial occlusion allowing the balloon catheter to be advanced across the lesion to further reduce the arterial stenosis. Early clinical trials of laser angioplasty in the peripheral arteries have demonstrated the unsatisfactory results obtained with single bare optical fibers used to deliver the laser energy due to the small channels created,3 and the high incidence of arterial perforatior not only increase the size of the lumen created with the laser fiber but also reduce the risk of mechanical perforation, we have modified the distal end with a spherical lens that increases the spot size of the laser fiber and provides an atraumatic tip for the optical fiber. This report describes the first human clinical trials including 6-month follow-up of patients treated with a lensed fiber-tip laser delivery system designed for percutaneous revascularization of peripheral vascular obstructive lesions not amenable to conventional balloon angioplasty.

AB - Percutaneous transluminal balloon angioplasty of obstructed iliac and femoral arteries is the therapy of choice in the management of selected patients with peripheral vascular disease. The advantages of percutaneous balloon angioplasty include a reduction in the morbidity of the revascularization procedure, a shorter hospital stay, and comparable 5-year patency rates when compared with surgical revascularization in selected patients.1,2 One of the limitations of balloon angioplasty is that a lesion must first be crossed with a guidewire. The inability to cross occlusions with a guidewire is the most common cause of failure of the procedure. Laser angioplasty may have a role as an adjunct to balloon angioplasty by recanalizing lesions that cannot be traversed with a guidewire. The laser can create a channel through the arterial occlusion allowing the balloon catheter to be advanced across the lesion to further reduce the arterial stenosis. Early clinical trials of laser angioplasty in the peripheral arteries have demonstrated the unsatisfactory results obtained with single bare optical fibers used to deliver the laser energy due to the small channels created,3 and the high incidence of arterial perforatior not only increase the size of the lumen created with the laser fiber but also reduce the risk of mechanical perforation, we have modified the distal end with a spherical lens that increases the spot size of the laser fiber and provides an atraumatic tip for the optical fiber. This report describes the first human clinical trials including 6-month follow-up of patients treated with a lensed fiber-tip laser delivery system designed for percutaneous revascularization of peripheral vascular obstructive lesions not amenable to conventional balloon angioplasty.

UR - http://www.scopus.com/inward/record.url?scp=0025608674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025608674&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(90)90553-D

DO - 10.1016/0002-9149(90)90553-D

M3 - Article

C2 - 2147538

AN - SCOPUS:0025608674

VL - 66

SP - 1526

EP - 1528

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 20

ER -